Piramal Pharma cuts exposure to Chinese raw materials to reduce supply risk
Piramal Pharma moved higher.
· BS Companies
Piramal is among global drugmakers increasingly seeking to reduce their reliance on China for pharmaceutical ingredients and manufacturing, amid rising geopolitical…
The analysis
Against that, the stock is +3.5% on the day at ₹238.91, and has returned +21.4% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The pharma & healthcare sector has moved -0.9% over the same period, so Piramal Pharma is running 22.3 points ahead of its peers.
For Piramal Pharma, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Market context
- The 3 companies named span 3 sectors, so these are separate company stories rather than one sector-wide move.
- On the day, 1 of 3 are higher: Piramal Pharma leads at +3.5% and Piramal Finance trails at -2.6%.
- Over three months: Piramal Pharma +21.4% against Pharma & Healthcare -0.9% (22.3 points ahead); Piramal Finance -10.4% against Financial Services -14.9% (4.5 points ahead); Reliance Industries -9.9% against Oil & Energy -5.7% (4.2 points behind).
- At least 25% below the 52-week high: Reliance Industries (27%).
- Trading well above normal today: Piramal Pharma at 2.6 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Piramal PharmaPPLPHARMA · Pharma & Healthcare | ₹238.91 | +3.5% | +15.7% | +21.4% | 0.0% | 2.6× | — |
| Piramal FinancePIRAMALFIN · Financial Services | ₹1,817.00 | -2.6% | -11.1% | -10.4% | -21.4% | 0.6× | — |
| Reliance IndustriesRELIANCE · Oil & Energy | ₹1,164.90 | -0.2% | -1.9% | -9.9% | -26.8% | 1.0× | — |
Pharma & Healthcare
1M -0.6% · 3M -0.9%
Piramal Pharma
Financial Services
1M -8.8% · 3M -14.9%
Piramal Finance
Oil & Energy
1M -4.8% · 3M -5.7%
Reliance Industries
Prices as of 30 Oct 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Record earnings! 5 big takeaways from RIL Q2 results investors should watch for Monday trading
Jio Financial Services share price decoded: Reliance stock performance amid Jio Platforms IPO buzz; target, outlook
Markets hit 6-month high in Oct on IT rally, Jio Platforms IPO frenzy
Mukesh Ambani stocks: Reliance Industries vs Jio Platforms shares compared - RIL or JPL? What to buy? Experts' views